These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1180093)

  • 1. Presence of substance P-like immunoreactivity in plasma from man and dog.
    Nilsson G; Pernow B; Fischer GH; Folkers K
    Acta Physiol Scand; 1975 Aug; 94(4):542-4. PubMed ID: 1180093
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassay measurement of substance P release following a meat meal.
    Akande B; Reilly P; Modlin IM; Jaffe BM
    Surgery; 1981 Mar; 89(3):378-83. PubMed ID: 6162204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue concentration and release of substance P-like immunoreactivity in the dental pulp.
    Brodin E; Gazelius B; Olgart L; Nilsson G
    Acta Physiol Scand; 1981 Feb; 111(2):141-9. PubMed ID: 6169251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two substance P antisera.
    Brodin E; Nilsson G; Folkers K
    Acta Physiol Scand; 1982 Jan; 114(1):53-7. PubMed ID: 6182748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma substance P levels in fibrositis.
    Reynolds WJ; Chiu B; Inman RD
    J Rheumatol; 1988 Dec; 15(12):1802-3. PubMed ID: 2466119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced levels of calcitonin gene-related peptide (CGRP) but not substance P during and after treatment of severe hypertension in man.
    Edvinsson L; Ekman R; Thulin T
    J Hum Hypertens; 1989 Aug; 3(4):267-70. PubMed ID: 2477545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P-like immunoreactivity in plasma and adrenal medulla of rats with spontaneous hypertension and WKY rats under acute stress.
    Rathsack R; Oehme P; Roske I; Hilse H
    Biomed Biochim Acta; 1983; 42(7-8):955-8. PubMed ID: 6197066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance P-like immunoreactivity.
    Lundberg JM; Hökfelt T; Fahrenkrug J; Nilsson G; Terenius L
    Acta Physiol Scand; 1979 Nov; 107(3):279-81. PubMed ID: 94238
    [No Abstract]   [Full Text] [Related]  

  • 9. Release of substance-P-like immunoreactivity in dog paw lymph after scalding injury.
    Jonsson CE; Brodin E; Dalsgaard CJ; Haegerstrand A
    Acta Physiol Scand; 1986 Jan; 126(1):21-4. PubMed ID: 2420151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intestine as source of immunoreactive substance P in plasma of the cat.
    Gamse R; Mroz E; Leeman S; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):17-21. PubMed ID: 723966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior of blood pressure and substance P-like immunoreactivity (SPLIR) in plasma of rats with genetically fixed hypertension (SHR) under chronic intermittent immobilization].
    Roske I; Rathsack R; Hilse H; Oehme P
    Biomed Biochim Acta; 1983; 42(6):731-6. PubMed ID: 6196024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of GABAA receptor alpha 1 subunit-like immunoreactivity in comparison with that of enkephalin and substance P in the rat forebrain.
    Marksteiner J; Lassnig E; Humpel C; Sieghart W; Kaufmann W; Saria A
    Synapse; 1995 Jun; 20(2):165-74. PubMed ID: 7570347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood pressure and substance P-like immunoreactivity in the adrenal medulla and plasma of normotensive Wistar Kyoto rats and spontaneously hypertensive rats of varying age under acute stress].
    Roske I; Rathsack R; Oehme P; Hilse H; Hecht K
    Pharmazie; 1983 Dec; 38(12):885-6. PubMed ID: 6199800
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma concentrations of immunoreactive beta-endorphin and substance P in patients undergoing surgery under general vs spinal anaesthesia.
    Janicki PK; Erskine R; van der Watt ML
    Horm Metab Res; 1993 Feb; 25(2):131-3. PubMed ID: 7681422
    [No Abstract]   [Full Text] [Related]  

  • 15. [The nature of the changes in the content of regulatory peptides in the pulmonary vascular bed].
    Beliakov NA; Meshkova ME; Solov'eva IE
    Fiziol Zh SSSR Im I M Sechenova; 1992 May; 78(5):47-53. PubMed ID: 1281796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of substance P-like immunoreactivity (SPLI) in tissues of dog, rat and mouse.
    Brodin E; Nilsson G
    Acta Physiol Scand; 1981 Jul; 112(3):305-12. PubMed ID: 6170209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and application of a novel N-terminal directed substance P antiserum.
    Lee CM; Emson PC; Iversen LL
    Life Sci; 1980 Aug; 27(7):535-43. PubMed ID: 6158641
    [No Abstract]   [Full Text] [Related]  

  • 18. Localization of substance P- and enkephalin-like immunoreactivity in the human paravertebral sympathetic ganglia.
    Del Fiacco M; Levanti MC; Contini M; Montisci R; Savona G; Brotzu G
    Basic Appl Histochem; 1985; 29(4):309-20. PubMed ID: 2420319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P and nasal secretion in dog, rat, and man.
    Petersson G; McCaffrey TV; Malm L
    Ann Allergy; 1989 May; 62(5):410-4. PubMed ID: 2470273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of endogenous and exogenous substance-P in human plasma.
    Corbally N; Powell D; Tipton KF
    Biochem Pharmacol; 1990 Apr; 39(7):1161-6. PubMed ID: 1690997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.